HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Murakami Selected Research

N,N'- hexamethylenebis(4- carbamoyl- 1- decylpyridinium bromide)

4/2017Evaluation of the effectiveness of the potent bis-quaternary ammonium compound, 4,4'-(α,ω-hexametylenedithio) bis (1-octylpyridinium bromide) (4DTBP-6,8) on Pseudomonas aeruginosa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Murakami Research Topics

Disease

15Neoplasms (Cancer)
12/2021 - 01/2000
6Inflammation (Inflammations)
04/2014 - 04/2000
6Infections
04/2014 - 01/2000
6Neoplasm Metastasis (Metastasis)
11/2001 - 01/2000
5Obesity
08/2007 - 04/2000
5Insulin Resistance
08/2006 - 04/2000
4Carcinoma (Carcinomatosis)
06/2005 - 01/2000
4Body Weight (Weight, Body)
12/2001 - 09/2000
3Necrosis
11/2022 - 07/2000
3Rheumatoid Arthritis
11/2022 - 01/2019
3Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2010 - 08/2001
3Stomach Neoplasms (Stomach Cancer)
12/2008 - 09/2001
3Renal Insufficiency (Renal Failure)
07/2000 - 02/2000
2Dyspepsia (Indigestion)
01/2018 - 09/2001
2Pneumonia (Pneumonitis)
06/2014 - 10/2000
2Ischemia
05/2014 - 09/2000
2Ulcerative Colitis
05/2014 - 11/2001
2Reperfusion Injury
05/2014 - 09/2000
2Alzheimer Disease (Alzheimer's Disease)
01/2011 - 10/2007
2Gastritis
08/2010 - 01/2004
2Breast Neoplasms (Breast Cancer)
11/2008 - 03/2000
2Constipation
05/2007 - 05/2006
2Pleural Effusion (Pleural Effusions)
12/2003 - 07/2000
2Fever (Fevers)
12/2003 - 02/2000
2Ascites
12/2003 - 07/2000
2Leiomyoma (Uterine Fibroids)
11/2001 - 10/2000
2Type 2 Diabetes Mellitus (MODY)
10/2001 - 08/2001
2Polyps
09/2001 - 02/2001
2Aortic Valve Insufficiency (Aortic Regurgitation)
05/2001 - 11/2000
2Lung Neoplasms (Lung Cancer)
04/2001 - 09/2000
2Vascular System Injuries
11/2000 - 01/2000
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2000 - 07/2000
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2020
1Central Nervous System Lupus Vasculitis
03/2019
1Osteoporosis
01/2019
1Gastroesophageal Reflux (GERD)
01/2018
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
01/2018
1Halitosis
05/2017
1Cross Infection (Nosocomial Infection)
04/2017
1Neuralgia (Stump Neuralgia)
08/2015

Drug/Important Bio-Agent (IBA)

5Pharmaceutical PreparationsIBA
11/2022 - 03/2000
4Dietary FiberFDA Link
07/2011 - 05/2006
4Messenger RNA (mRNA)IBA
08/2007 - 01/2000
3AntigensIBA
11/2022 - 01/2001
3SteroidsIBA
11/2019 - 02/2000
3Anti-Bacterial Agents (Antibiotics)IBA
05/2014 - 04/2000
3Proteins (Proteins, Gene)FDA Link
01/2014 - 07/2000
3Amyloid (Amyloid Fibrils)IBA
11/2012 - 09/2000
3Adrenal Cortex Hormones (Corticosteroids)IBA
07/2011 - 07/2000
3Triglycerides (Triacylglycerol)IBA
10/2010 - 08/2001
3Fatty Acids (Saturated Fatty Acids)IBA
10/2008 - 10/2001
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2005 - 01/2000
3LeptinIBA
11/2001 - 08/2001
3TAC 101IBA
11/2001 - 09/2000
3Benzoic Acid (Potassium Benzoate)FDA Link
11/2001 - 09/2000
3Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
09/2000 - 01/2000
2Biological ProductsIBA
11/2022 - 01/2001
2DNA (Deoxyribonucleic Acid)IBA
06/2014 - 12/2008
2Antifungal AgentsIBA
07/2011 - 04/2000
2AcidsIBA
10/2010 - 07/2000
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
10/2010 - 10/2008
2salicylhydroxamic acid (SHAM)IBA
05/2007 - 11/2000
2Transforming Growth Factor beta (TGF-beta)IBA
09/2005 - 06/2004
2Immunoglobulin G (IgG)IBA
01/2004 - 04/2000
2Immunoglobulin M (IgM)IBA
12/2003 - 04/2000
2Doxorubicin (Adriamycin)FDA LinkGeneric
12/2003 - 09/2000
2CytokinesIBA
12/2003 - 11/2001
2ThiazolidinedionesIBA
11/2001 - 10/2001
2AdiponectinIBA
11/2001 - 08/2001
2PPAR gammaIBA
11/2001 - 10/2001
2Estrogens (Estrogen)FDA Link
11/2001 - 10/2000
2RetinoidsIBA
11/2001 - 04/2000
2Aromatase (CYP19)IBA
11/2001 - 10/2000
2Rifampin (Rifampicin)FDA LinkGeneric
10/2001 - 03/2001
2Matrix Metalloproteinase 14 (MT1-MMP)IBA
05/2001 - 07/2000
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2000 - 09/2000
2LipopolysaccharidesIBA
11/2000 - 01/2000
2AndrogensIBA
10/2000 - 07/2000
2matrigelIBA
07/2000 - 07/2000
2CholesterolIBA
07/2000 - 02/2000
2AntibodiesIBA
04/2000 - 01/2000
1Antirheumatic Agents (DMARD)IBA
11/2022
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
11/2022
1Superoxide Dismutase-1IBA
01/2020
1OsteopontinIBA
03/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1liu-jun-zi-tangIBA
01/2018
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
01/2018
13-hydroxypropionaldehydeIBA
05/2017
1Sulfhydryl Compounds (Thiols)IBA
05/2017
1Disinfectants (Biocides)IBA
04/2017
14,4'- (1,6- hexamethylenedithio)bis(1- octylpyridinium)IBA
04/2017
1N,N'- hexamethylenebis(4- carbamoyl- 1- decylpyridinium bromide)IBA
04/2017

Therapy/Procedure

12Therapeutics
06/2014 - 07/2000
4Oral Administration
01/2011 - 06/2000
3Drug Therapy (Chemotherapy)
10/2013 - 07/2000
2Renal Dialysis (Hemodialysis)
01/2011 - 09/2000
2Segmental Mastectomy (Lumpectomy)
06/2005 - 03/2004
1Transplantation
12/2021
1Radiotherapy
11/2019